RNAZ logo

TransCode Therapeutics, Inc. Common Stock


RNAZ: TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat cancer through the intelligent design and effective delivery of RNA therapeutics. The company's therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian, and colon cancer, glioblastomas, and others.


Show RNAZ Financials

Consumer Interest
SEC Filings

Recent trades of RNAZ by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by RNAZ's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of RNAZ in WallStreetBets Daily Discussion


Recent insights relating to RNAZ

CNBC Recommendations

Recent picks made for RNAZ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RNAZ

Corporate Flights

Flights by private jets registered to RNAZ